Jove
Visualize
Contact Us

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of <i>Bacillus velezensis</i> YL2021-Derived Siderophores for Biocontrol of Phytophthora Blight and Downy Mildew.

Plant disease·2026
Same author

Identification of β-Lapachone as a Potent USP22 Inhibitor That Suppresses Cancer Stemness and Enhances Chemosensitivity in Lung Adenocarcinoma.

International journal of molecular sciences·2026
Same author

Assessing the Readiness of Augmented Reality for Industrial Assembly: A Deployment Study Comparing Immersive and Non-Immersive Solutions.

IEEE transactions on visualization and computer graphics·2026
Same author

Author Correction: Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury.

Nature·2025
Same author

Relation of Visual Function, Retinal Thickness by Optical Coherence Tomography, and MRI Brain Volume in Pediatric-Onset Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Differential Sex-Based Enrolment into US-Registered Glaucoma Clinical Trials: A Cross-Sectional Study.

Seminars in ophthalmology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 14, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

523

Validation of Non-Small Cell Lung Cancer Clinical Insights Using a Generalized Oncology Natural Language Processing

Rachel C Kenney1,2, Xiaoren Chen1, Kazuki Shintani1

  • 1Optum Insight, Optum, Eden Prairie, MN.

JCO Clinical Cancer Informatics
|September 4, 2024
PubMed
Summary

Natural language processing (NLP) accurately extracts non-small cell lung cancer (NSCLC) data from medical notes. This validated model shows high precision and recall, supporting cancer research and clinical trials.

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.5K

Related Experiment Videos

Last Updated: Jun 14, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

523
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.5K

Area of Science:

  • Oncology
  • Medical Informatics
  • Natural Language Processing

Background:

  • Limited studies have explored Natural Language Processing (NLP) applications in non-small cell lung cancer (NSCLC).
  • Extracting structured data from unstructured clinical notes is crucial for cancer research.

Purpose of the Study:

  • To validate an NLP model's ability to extract NSCLC concepts from free-text medical records.
  • To convert extracted concepts into structured, interpretable data for research.

Main Methods:

  • An NLP model, previously validated on a broad oncology cohort, was applied to 200 NSCLC patient records.
  • Key concepts (neoplasm, histology, stage, TNM, metastasis) were manually abstracted as a gold standard.
  • NLP output was compared against the gold standard using precision and recall metrics.

Main Results:

  • The NLP model achieved high precision and recall for all extracted NSCLC concepts.
  • Scores included: Lung neoplasm (100%, 100%), NSCLC histology (99%, 88%), Stage (98.8%, 92%), and Metastasis site (97%, 89%).
  • High scores indicate accurate and comprehensive data extraction.

Conclusions:

  • The validated NLP model demonstrates high precision and recall with real-world clinical data.
  • This generalizable oncology NLP model reliably supports NSCLC research and clinical trials.